Indian Diabetes Market Size to Reach US$ 8.8 Billion by 2028 | Industry CAGR of 16%

IMARC Group's report titled "Indian Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics", The Indian diabetes market size reached US$ 3.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.8 Billion by 2028, exhibiting a growth rate (CAGR) of 16% during 2023-2028.

Diabetes refers to a chronic disease caused by improper production of or response to insulin in the body resulting in high blood sugar levels. It can result in various complications, such as visual, cardiovascular, renal, and neural disorders. Some of the commonly available drugs used for treating diabetes include insulin injections, metformin, meglitinides, etc. They aid in identifying blood sugar levels accurately, determining the effectiveness of diabetes treatment, lowering the instances of hyperglycemia and hypoglycemia, etc.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/india-diabetes/requestsample

Indian Diabetes Market Trends and Drivers:

The increasing prevalence of obesity, owing to the rising stress levels, unhealthy dietary habits of individuals, and lack of proper exercise, is primarily driving the India diabetes market. Additionally, the expanding geriatric population, who are more susceptible to such chronic disease, and the launch of numerous favorable initiatives by government bodies aimed at providing free treatment and insulin to patients are acting as significant growth-inducing factors. Apart from this, the inflating need for diabetes care devices to treat and manage symptoms and complications associated with the diseases, including respiratory issues, liver and kidney failure, cardiovascular conditions, etc., the widespread adoption of advanced technologies, and the low-cost of drug production are also propelling the market growth across India. Moreover, the introduction of non-invasive and low-cost insulin delivery systems, digital diabetes management platforms, and wearable devices is further stimulating the market growth. Besides this, extensive R&D activities by key market players, the growing pharmaceutical contract manufacturing, and continuous improvements in healthcare infrastructures are expected to fuel the India diabetes market over the forecasted period.

Key Insights from the market

On the basis of type, the market has been segmented into type-1 and type-2 diabetes. Currently, type-2 diabetes accounts for the maximum share.

On the basis of region, the market has been segregated into urban and rural regions. The prevalence of diabetes in the urban population is much higher as opposed to the rural areas.

Based on gender, the market has been classified into males and females. Amongst these, the prevalence of diabetes in males is higher in comparison with females.

On the basis of age group, age group of 40-59 years holds the largest share of the diabetes population in India. It is followed by age group of 60-79 years and 20-39 years.

Explore full report with table of contents: https://www.imarcgroup.com/india-diabetes

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Contact US

IMARC Group

Email: sales@imarcgroup.com

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Address: 134 N 4th St. Brooklyn, NY 11249, USA 

Follow us on Twitter: @imarcglobal

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.